Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Metabotropic glutamate receptor 5 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | serine:threonine protein kinase | 0.0256 | 0.4877 | 0.4877 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.006 | 0.1042 | 0.1042 |
Echinococcus granulosus | myosin light chain kinase smooth muscle | 0.0256 | 0.4877 | 0.4877 |
Echinococcus multilocularis | myosin light chain kinase, smooth muscle | 0.0256 | 0.4877 | 0.4877 |
Loa Loa (eye worm) | CAMK protein kinase | 0.0007 | 0.0005 | 0.0046 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0007 | 0.0005 | 0.0046 |
Onchocerca volvulus | Metabotropic glutamate receptor homolog | 0.0008 | 0.002 | 1 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0007 | 0.0005 | 0.0046 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0041 | 0.0666 | 0.0666 |
Loa Loa (eye worm) | glutamate receptor | 0.0049 | 0.0821 | 0.7879 |
Brugia malayi | Receptor family ligand binding region containing protein | 0.0013 | 0.011 | 0.1339 |
Onchocerca volvulus | 0.0007 | 0.0005 | 0.2366 | |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0041 | 0.0666 | 0.6994 |
Echinococcus granulosus | GPCR family 3 C terminal | 0.0008 | 0.002 | 0.002 |
Echinococcus multilocularis | titin | 0.0007 | 0.0005 | 0.0005 |
Loa Loa (eye worm) | receptor family ligand binding region containing protein | 0.0013 | 0.011 | 0.1055 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0007 | 0.0005 | 0.0058 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0044 | 0.0731 | 0.8905 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0518 | 1 | 1 |
Loa Loa (eye worm) | metabotropic GABA-B receptor subtype 2 | 0.0013 | 0.011 | 0.1055 |
Onchocerca volvulus | Poor gastrulation protein homolog | 0.0008 | 0.002 | 1 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.006 | 0.1042 | 0.1042 |
Echinococcus multilocularis | serine:threonine protein kinase | 0.0256 | 0.4877 | 0.4877 |
Schistosoma mansoni | titin | 0.0007 | 0.0005 | 0.005 |
Schistosoma mansoni | hypothetical protein | 0.0008 | 0.002 | 0.0211 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0041 | 0.0666 | 0.0666 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0007 | 0.0005 | 0.005 |
Echinococcus granulosus | titin | 0.0007 | 0.0005 | 0.0005 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0056 | 0.0952 | 1 |
Brugia malayi | protein unc-22 | 0.0007 | 0.0005 | 0.0058 |
Brugia malayi | metabotropic GABA-B receptor subtype 2 | 0.0008 | 0.002 | 0.0244 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1042 | 1 |
Echinococcus granulosus | titin | 0.0007 | 0.0005 | 0.0005 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0049 | 0.0821 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0008 | 0.002 | 0.0192 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.0024 | 0.0331 | 0.403 |
Loa Loa (eye worm) | glutamate receptor | 0.0019 | 0.0241 | 0.2313 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0024 | 0.0331 | 0.3476 |
Echinococcus multilocularis | GPCR, family 3, C terminal | 0.0008 | 0.002 | 0.002 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.011 | 0.1055 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = 43 % | Positive allosteric modulation of rat mGlu5 receptor expressed in HEK293 cells relative to glutamate | ChEMBL. | 24961642 |
EC50 (binding) | = 5.54 | Positive allosteric modulation of rat mGlu5 receptor expressed in HEK293 cells | ChEMBL. | 24961642 |
EC50 (binding) | = 2907 nM | Positive allosteric modulation of rat mGlu5 receptor expressed in HEK293 cells | ChEMBL. | 24961642 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.